enVVeno Medical Corp (NVNO) stock
NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.77+0.00 (0.00%)
Close on Nov 18, 2026Market cap $4.01MP/E –Yield –
enVVeno Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
enVVeno Medical's operating cash flow for the twelve months ending Sep 30, 2026 was -$13.41M. For fiscal 2025 it was -$15.57M. The highest annual figure on record is -$4.20M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.57M | – |
| FY2024 | Dec 31, 2024 | -$16.84M | – |
| FY2023 | Dec 31, 2023 | -$18.86M | – |
| FY2022 | Dec 31, 2022 | -$15.62M | – |
| FY2021 | Dec 31, 2021 | -$11.85M | – |
| FY2020 | Dec 31, 2020 | -$7.68M | – |
| FY2019 | Dec 31, 2019 | -$5.90M | – |
| FY2018 | Dec 31, 2018 | -$6.36M | – |
| FY2017 | Dec 31, 2017 | -$4.20M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.18M | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.44M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.39M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.72M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.02M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.11M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.28M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.55M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.97M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.21M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.56M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.86M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.48M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.96M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.32M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.10M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.23M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.84M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.61M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.59M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.32M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.15M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.35M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.43M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.49M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.44M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.74M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.54M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.63M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.27M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.21M | – |
See a number that looks wrong?